netFormulary
 Report : A-Z CDF items in Formulary 19/11/2018 21:48:29
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01 Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq, Cabometyx
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Daratumumab DARZALEX
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Hydrochloride Caelyx
08.01.05 Formulary Cancer Drugs Fund Gemtuzumab ozogamicin MYLOTARG
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Formulary Cancer Drugs Fund Inotuzumab ozogamicin BESPONSA
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro
08.01.05 Formulary Cancer Drugs Fund Lenvatinib Kisplyx, Lenvima
08.01.05 Formulary Cancer Drugs Fund Liposomal Cytarabine-Daunorubicin Vyxeos
08.01.05 Formulary Cancer Drugs Fund Lutetium (177Lu) oxodotreotide Lutathera
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance
08.01.05 Formulary Cancer Drugs Fund Niraparib Zejula
08.01.05 Formulary Cancer Drugs Fund Nivolumab Opdivo
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab  Gazyvaro
08.01.05 Formulary Cancer Drugs Fund Olaratumab Lartruvo
08.01.05 Formulary Cancer Drugs Fund Osimertinib Tagrisso
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist
08.01.05 Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto
Dorset